Individuals' responses to global CHD risk: A focus group study

Patient Education and Counseling

Volumn 76, Issue 2, 2009, Pages 233-239

  Sheridan, Stacey L ^a,b   Behrend, Lindy ^a,b   Vu, Maihan B ^b   Meier, Andrea ^b   Griffith, Jennifer M ^b   Pignone, Michael P ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cardiovascular disease; Decision making; Focus groups

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DECISION MAKING; FEMALE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MALE; MEDICAL INFORMATION; MOTIVATION; PATIENT ATTITUDE; PRIORITY JOURNAL; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEM; HEALTH; INFORMATION PROCESSING; MIDDLE AGED; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; UNITED STATES;

AGED; CORONARY ARTERY DISEASE; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; FOCUS GROUPS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; UNITED STATES; WORLD HEALTH; GLOBAL HEALTH;

EID: 67650448045     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2009.01.010     Document Type: Article

References (46)

1. American Heart Association. Heart and stroke statistics-2008 update (2008), American Heart Association, Dallas, TX
2. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J Am Med Assoc 290 (2003) 199-206
3. Thorndike A.N., Regan S., and Rigotti N.A. The treatment of smoking by US physicians during ambulatory visits: 1994-2003. Am J Public Health 97 (2007) 1878-1883
4. Ajani U.A., Ford E.S., Greenland K.J., Giles W.H., and Mokdad A.H. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 30 (2006) 74-77
5. Hyre A.D., Muntner P., Menke A., Raggi P., and He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 17 (2007) 548-555
6. Lovibond S.H., Birrell P.C., and Langeluddecke P. Changing coronary heart disease risk-factor status: the effects of three behavioral programs. J Behav Med 9 (1986) 415-437
7. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., Franklin B.A., Goldstein L.B., Greenland P., Grundy S.M., Hong Y., Miller N.H., Lauer R.M., Ockene I.S., Sacco R.L., Sallis Jr. J.F., Smith Jr. S.C., Stone N.J., and Taubert K.A. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002) 388-391
8. Sheridan S.L., Harris R.P., and Woolf S.H. Shared decision making about screening and chemoprevention. A suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med 26 (2004) 56-66
9. Kreuter M.W., and Strecher V.J. Changing inaccurate perceptions of health risk: results from a randomized trial. Health Psychol 14 (1995) 56-63
10. Avis N.E., Smith K.W., and McKinlay J.B. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed?. Am J Public Health 79 (1989) 1608-1612
11. Paterson J.M., Llewellyn-Thomas H.A., and Naylor C.D. Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk. Health Expect 5 (2002) 3-15
12. Christian A.H., Mochari H.Y., and Mosca L.J. Coronary heart disease in ethnically diverse women: risk perception and communication. Mayo Clin Proc 80 (2005) 1593-1599
13. Lalonde L., O'Connor A.M., Drake E., Duguay P., Lowensteyn I., and Grover S.A. Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease. Pharmacotherapy 24 (2004) 909-922
14. van Steenkiste B., van der Weijden T., Timmermans D., Vaes J., Stoffers J., and Grol R. Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention. Patient Educ Couns 55 (2004) 301-307
15. Lewis D.K., Robinson J., and Wilkinson E. Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes. Brit Med J 327 (2003) 841
16. Sheridan S.L., and Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? a systematic review of the literature. BMC Health Serv Res 8 (2008) 60
17. Grover S.A., Lowensteyn I., Joseph L., Kaouache M., Marchand S., Coupal L., and Boudreau G. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Arch Intern Med 167 (2007) 2296-2303
18. Edelman D., Oddone E.Z., Liebowitz R.S., Yancy Jr. W.S., Olsen M.K., Jeffreys A.S., Moon S.D., Harris A.C., Smith L.L., Quillian-Wolever R.E., and Gaudet T.W. A multidimensional integrative medicine intervention to improve cardiovascular risk. J Gen Intern Med 21 (2006) 728-734
19. Weymiller A.J., Montori V.M., Jones L.A., Gafni A., Guyatt G.H., Bryant S.C., Christianson T.J., Mullan R.J., and Smith S.A. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 167 (2007) 1076-1082
20. Williams G.C., McGregor H., Sharp D., Kouides R.W., Levesque C.S., Ryan R.M., and Deci E.L. A self-determination multiple risk intervention trial to improve smokers' health. J Gen Intern Med 21 (2006) 1288-1294
21. Krones T., Keller H., Sonnichsen A., Sadowski E.M., Baum E., Wegscheider K., Rochon J., and Donner-Banzhoff N. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Ann Fam Med 6 (2008) 218-227
22. Krueger R.A. Focus groups: a practical guide for applied research (2000), Sage, Thousand Oaks, CA
23. Executive summary of the third report of the national cholesterol education program NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults adult treatment panel III. J Am Med Assoc 2001;285:2486-97.
24. Hayden M., Pignone M., Phillips C., and Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136 (2002) 161-172
25. Sheridan S.L., Shadle J., Simpson Jr. R.J., and Pignone M.P. The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Serv Res 6 (2006) 121
26. Pignone M., Sheridan S.L., Lee Y.Z., Kuo J., Phillips C., Mulrow C., and Zeiger R. Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention. Prev Cardiol 7 (2004) 26-33
27. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
28. Vasan R.S., Pencina M.J., Cobain M., Freiberg M.S., and D'Agostino R.B. Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med 143 (2005) 473-480
29. Fishbein M. The role of theory in HIV prevention. AIDS Care 12 (2000) 273-278
30. Williams G.C., Gagne M., Ryan R.M., and Deci E.L. Facilitating autonomous motivation for smoking cessation. Health Psychol 21 (2002) 40-50
31. Strauss A.L., and Corbin J. Basics of qualitative research: grounded theory procedures and techniques (1990), Sage, Newbury Park, CA
32. Schwartz L.M., Woloshin S., Black W.C., and Welch H.G. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 127 (1997) 966-972
33. Edwards A.G., Evans R., Dundon J., Haigh S., Hood K., and Elwyn G.J. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev (2006) CD001865
34. O'Connor A.M., Stacey D., Entwistle V., Llewellyn-Thomas H., Rovner D., Holmes Rovner M., Tait V., Tetroe J., Fiset V., Barry M., and Jones J. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2003) CD001431
35. World Health Organization. Adherence to long-term therapies: evidence for action (2003), World Health Organization, Geneva (Switzerland)
36. Walter F.M., Emery J., Braithwaite D., and Marteau T.M. Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med 2 (2004) 583-594
37. Frich J.C., Ose L., Malterud K., and Fugelli P. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study. Ann Fam Med 4 (2006) 198-204
38. Elwyn G., O'Connor A., Stacey D., Volk R., Edwards A., Coulter A., Thomson R., Barratt A., Barry M., Bernstein S., Butow P., Clarke A., Entwistle V., Feldman-Stewart D., Holmes-Rovner M., Llewellyn-Thomas H., Moumjid N., Mulley A., Ruland C., Sepucha K., Sykes A., and Whelan T. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Brit Med J 333 (2006) 417
39. Feldman-Stewart D., Kocovski N., McConnell B.A., Brundage M.D., and Mackillop W.J. Perception of quantitative information for treatment decisions. Med Decis Making 20 (2000) 228-238
40. Edwards A., Elwyn G., and Mulley A. Explaining risks: turning numerical data into meaningful pictures. Brit Med J 324 (2002) 827-830
41. Covey J. A meta-analysis of the effects of presenting treatment benefits in different formats. Med Decis Making 27 (2007) 638-654
42. McGettigan P., Sly K., O'Connell D., Hill S., and Henry D. The effects of information framing on the practices of physicians. J Gen Intern Med 14 (1999) 633-642
43. Edwards A., Elwyn G., Covey J., Matthews E., and Pill R. Presenting risk information-a review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun 6 (2001) 61-82
44. Moxey A., O'Connell D., McGettigan P., and Henry D. Describing treatment effects to patients. J Gen Intern Med 18 (2003) 948-959
45. Lipkus I.M. Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making 27 (2007) 696-713
46. Goodyear-Smith F., Arroll B., Chan L., Jackson R., Wells S., and Kenealy T. Patients prefer pictures to numbers to express cardiovascular benefit from treatment. Ann Fam Med 6 (2008) 213-217